#NewProfilePic

Looking forward to van guideline tweeter-fest next week and auc dosing. If you want to use a drug, use it right. Imagine if a cardiologist said a TEE was too hard vs TTE to diagnose IE. Not acceptable, nor should be maintaining troughs in AKI sweet spot. #sipd #ajhp #arlg #idsa

Amit Pai got promoted in academia for tenth time. Amazing dude. Congratulations to Amit for promotion to professor at Michigan. The man is full business and functions at a level higher then all of us, blessed to be his friend. #sidp #ashp #accp

I do have to say that working at home with my daughter next to me doing her schoolwork has been one of the few blessings of the stay at home order.

I really enjoyed interacting with everyone last night on #vancochat. Since we are moving to vancomycin auc-guided dosing, we should consider for aminoglycosides as well pubmed.ncbi.nlm.nih.gov/30403305/ #sidp #ASHP

NEW🔥🔥 #JACnews by tom lodise Brian Tsuji Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model. #IDTwitter academic.oup.com/jac/advance-ar…

Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 Brian Tsuji Bug Pharmacist 💊🧫 Tim Gauthier Chris Bland Marc H. Scheetz ACCP INFD PRN This is one of the professional rewarding collaborations I have been involved in recent years. It was a honor to sit with Brian and his group at the first pk-pd table!

It was a pleasure working with Nick and Monique on this paper! A lot of thoughtful discussions and debates on the grayness of available data and its interpretation. We look forward to your feedback.

New pub with best friend and colleague Nimish Patel. Examines 30- day readmissions among pts on vanco who experienced AKI vs no AKI. Even modest increases in Scr results in long-term consequences, likely due to distal organ dysfunction or organ cross talk aac.asm.org/content/early/…

In case you missed it | Tune into this podcast by Cesar Arias to hear how the #ARLGnetwork PROVIDE study led by tom lodise informed the new vancomycin guidelines. ASM IDSA NIAID News

🔥🔥Fresh from tom lodise in Pharmacotherapy: Delaying antibiotics in cases of GN-BSI led to worse outcomes, particularly if caused by carbapenem-resistant pathogens. Each day counts, demonstrating role for rapid diagnostic and timely intervention by #IDteam 👩‍🔬🧑‍⚕️💊🩺

VCU #InfectiousDiseases expert Amy Pakyz dreamed of being published in the journal CID. She told friends she could retire happy if that happened. She died early this year. Colleagues helped complete her revisions and resubmitted her paper ... and IT WAS JUST PUBLISHED IN CID.

“Now that ceftriaxone is generic” is my favorite #Breakpoints line from Ryan Shields ever. Listen as we review great data from David van Duin Steven Tong tom lodise Jason Roberts barbara jones and more! podcasts.apple.com/us/podcast/bre…

Happy Halloween!

Anticipate this will be excellent

The debate on optimal treatment of CRAB continues! It was a pleasure working on this study with ARLG, DMID, Dr. Wunderlink, Dr. Van Woert and other members of the ACUMIN team.

The #ARLGnetwork is dedicated to combating the growing #publichealth threat antibiotic-resistant bacteria pose worldwide w/ research targeting CDC’s top three #AntibacterialResistance threats. Learn more: arlg.org #WAAW #AMR #AntimicrobialAwarenessWeek